Europe Research Roundup: AstraZeneca, Ericsson, Gsk

H Lundbeck A/S

15/09/2022 08:32

Sept 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including
AstraZeneca, Ericsson and Gsk, on Thursday. 
    
    HIGHLIGHTS
     * AstraZeneca  AZN.L : Credit Suisse cuts to neutral from outperform 
     * BT Group Plc  BT.L : HSBC raises to buy from hold     
     * Ericsson  ERICb.ST : Credit Suisse cuts to underperform from outperform     
     * Gsk  GSK.L : Credit Suisse raises to neutral     
     * Novartis AG  NOVN.S : Credit Suisse cuts to underperform     
      
Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in
alphabetical order. 
    
     * Almirall SA  ALM.MC : Credit Suisse cuts target price to EUR 10 from EUR 12 
     * AstraZeneca  AZN.L : Credit Suisse cuts to neutral from outperform 
     * Benevolentai SA  BAI.AS : JP Morgan initiates coverage with neutral rating 
     * Benevolentai SA  BAI.AS : JP Morgan initiates coverage with EUR 5.10 target price 
     * BT Group Plc  BT.L : HSBC raises to buy from hold 
     * Dechra Pharmaceuticals Plc  DPH.L : RBC cuts target price to 4,000p from 4,200p 
     * Deutsche Telekom  DTEGN.DE : HSBC raises target price to EUR 26.5 from EUR 24 
     * D'Ieteren Group NV  IETB.BR : Jefferies initiates with buy rating and EUR 210 target price 
     * Ericsson  ERICb.ST : Credit Suisse cuts target price to SEK 69 from SEK 113 
     * Ericsson  ERICb.ST : Credit Suisse cuts to underperform from outperform 
     * Fever-Tree  FEVR.L : HSBC cuts target price to 780p from 800p 
     * Genmab A/S  GMAB.CO : Credit Suisse raises target price to DKK 2800 from DKK 2600 
     * Gsk  GSK.L : Credit Suisse cuts target price to 1430p from 1630p 
     * Gsk  GSK.L : Credit Suisse raises to neutral 
     * H Lundbeck A/S  HLUNb.CO : Credit Suisse cuts target price to DKK 31 from DKK 32.6 
     * H Lundbeck A/S  HLUNb.CO : Credit Suisse raises to neutral from underperform 
     * Hikma  HIK.L : Jefferies cuts target price to 2020p from 2290p 
     * Johnson Service Plc  JSG.L : HSBC cuts target price to 97p from 156p 
     * Johnson Service Plc  JSG.L : HSBC cuts to hold from buy 
     * KBC  KBC.BR : HSBC raises target price to EUR 73 from EUR 69.42 
     * Kion Group  KGX.DE : HSBC cuts target price to EUR 43 from EUR 74 
     * Marimekko Oyj  MEKKO.HE : Evli Research cuts target price to EUR 12 from EUR 13.2 
     * Marimekko Oyj  MEKKO.HE : Evli Research raises to buy from hold 
     * Merck KGaA  MRCG.DE : Jefferies raises target price to EUR 210 from EUR 205 
     * Nokia Oyj  NOKIA.HE : Credit Suisse raises target price to EUR 6.31 from EUR 5.45 
     * Nokia Oyj  NOKIA.HE : Credit Suisse raises to outperform from neutral 
     * Novartis AG  NOVN.S : Credit Suisse cuts target price to CHF 78 from CHF 88 
     * Novartis AG  NOVN.S : Credit Suisse cuts to underperform 
     * Proximus  PROX.BR : HSBC cuts target price to EUR 12.5 from EUR 16 
     * Redrow Plc  RDW.L : Jefferies cuts target price to 768p from 780p 
     * Roche Holding AG  ROG.S : Credit Suisse raises to outperform
     * Roche Holding AG  ROG.S : Credit Suisse raises target price to CHF 375 from CHF 350 
     * Sanofi  SASY.PA : Credit Suisse cuts target price to EUR 106 from EUR 110 
     * Swedish Orphan Biovitrum  SOBIV.ST : Jefferies raises target price to SEK 295 from SEK 260 
     * Technoprobe SpA  TPRO.MI : Berenberg initiates coverage with hold rating and EUR 7.90 PT 
     * Telecom Italia  TLIT.MI : HSBC cuts target price to EUR 0.2 from EUR 0.4 
     * Telecom Italia  TLIT.MI : HSBC cuts to hold from buy 
     * Telenor  TEL.OL : HSBC cuts target price to NOK 125 from NOK 135 
     * UCB SA  UCB.BR : Credit Suisse cuts target price to EUR 68 from EUR 86 
     * UCB SA  UCB.BR : Credit Suisse cuts to underperform from neutral 
     * Vodafone Group  VOD.L : HSBC cuts target price to 160p from 175p 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))